logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Shoaib, Muhammad, Dr
    Born in September 1978
    Individual (16 offsprings)
    Officer
    icon of calendar 2010-10-27 ~ now
    OF - Director → CIF 0
    Dr Muhammad Shoaib
    Born in September 1978
    Individual (16 offsprings)
    Person with significant control
    icon of calendar 2016-04-07 ~ now
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
  • 2
    Shoaib, Nosheen
    Born in July 1980
    Individual (2 offsprings)
    Officer
    icon of calendar 2010-10-27 ~ now
    OF - Director → CIF 0
    Nosheen Shoaib
    Born in July 1980
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2017-07-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

ALLIANCE DRUG DEVELOPMENT LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Par Value of Share
Class 1 ordinary share
12023-11-01 ~ 2024-10-31
Class 2 ordinary share
12023-11-01 ~ 2024-10-31
Class 3 ordinary share
12023-11-01 ~ 2024-10-31
Property, Plant & Equipment
22,395 GBP2024-10-31
15,263 GBP2023-10-31
Fixed Assets - Investments
28 GBP2024-10-31
28 GBP2023-10-31
Fixed Assets
22,423 GBP2024-10-31
15,291 GBP2023-10-31
Total Inventories
7,425 GBP2024-10-31
48,744 GBP2023-10-31
Debtors
587,599 GBP2024-10-31
817,654 GBP2023-10-31
Cash at bank and in hand
253,936 GBP2024-10-31
114,050 GBP2023-10-31
Current Assets
848,960 GBP2024-10-31
980,448 GBP2023-10-31
Creditors
Current
194,615 GBP2024-10-31
328,380 GBP2023-10-31
Net Current Assets/Liabilities
654,345 GBP2024-10-31
652,068 GBP2023-10-31
Total Assets Less Current Liabilities
676,768 GBP2024-10-31
667,359 GBP2023-10-31
Net Assets/Liabilities
673,154 GBP2024-10-31
666,029 GBP2023-10-31
Equity
Called up share capital
650 GBP2024-10-31
650 GBP2023-10-31
Retained earnings (accumulated losses)
672,504 GBP2024-10-31
665,379 GBP2023-10-31
Equity
673,154 GBP2024-10-31
666,029 GBP2023-10-31
Average Number of Employees
42023-11-01 ~ 2024-10-31
42022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
48,016 GBP2024-10-31
40,966 GBP2023-10-31
Property, Plant & Equipment - Disposals
Plant and equipment
-8,052 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
25,621 GBP2024-10-31
25,702 GBP2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
7,971 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Plant and equipment
-8,052 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment
Plant and equipment
22,395 GBP2024-10-31
15,264 GBP2023-10-31
Value of work in progress
7,425 GBP2024-10-31
48,744 GBP2023-10-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
26,433 GBP2024-10-31
Amounts falling due within one year, Current
8,910 GBP2023-10-31
Other Debtors
Current, Amounts falling due within one year
561,166 GBP2024-10-31
Amounts falling due within one year, Current
808,744 GBP2023-10-31
Debtors
Current, Amounts falling due within one year
587,599 GBP2024-10-31
Amounts falling due within one year, Current
817,654 GBP2023-10-31
Trade Creditors/Trade Payables
Current
3,153 GBP2024-10-31
1,257 GBP2023-10-31
Other Taxation & Social Security Payable
Current
42,564 GBP2024-10-31
31,050 GBP2023-10-31
Other Creditors
Current
148,898 GBP2024-10-31
296,073 GBP2023-10-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
3,614 GBP2024-10-31
1,330 GBP2023-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
300 shares2024-10-31
Class 2 ordinary share
300 shares2024-10-31
Class 3 ordinary share
50 shares2024-10-31

Related profiles found in government register
  • ALLIANCE DRUG DEVELOPMENT LIMITED
    Info
    Registered number 07420683
    icon of addressVenture House 2 Arlington Square, Downshire Way, Bracknell RG12 1WA
    PRIVATE LIMITED COMPANY incorporated on 2010-10-27 (15 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-27
    CIF 0
  • ALLIANCE DRUG DEVELOPMENT LTD
    S
    Registered number missing
    icon of addressOffice 13 Rockware Business Centre, 5 Rockware Avenue, Greenford, England, UB6 0AA
    Ltd Company
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of address393 Lordship Lane, London, United Kingdom
    Dissolved Corporate (2 parents)
    Equity (Company account)
    -65,250 GBP2017-11-30
    Person with significant control
    icon of calendar 2016-11-26 ~ dissolved
    CIF 1 - Ownership of shares – More than 25% but not more than 50%OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.